The Filings Report

Procter & Gamble Company

PGNYSECIK 80424Consumer Defensive / Household & Personal Productsfiscal year ends June74 quarters since 2008

Revenue, Q1 FY2027
$23.3B
+4.0% on Q1 FY2026
Net income
$4.7B
−0.4% on Q1 FY2026
Free cash flow
$4.4B
+4.6% on Q1 FY2026
Diluted EPS
$1.97
+1.0% on Q1 FY2026
Revenue, TTM
$87.9B
trailing four quarters
Net margin, TTM
18.2%
net income $16.0B
Free cash flow, TTM
$15.3B
$19.9B less $4.6B capex
Cash and equivalents
—
long-term debt $21.9B, Sep 30, 2026
Shares, 12-month change
−0.8%
2.32B shares, Sep 30, 2026
Buybacks, TTM
$5.0B
1.3% of market value
Dividends, TTM
$10.3B
2.8% of market value
Market value
$374.5B
at the close, buybacks

Latest quarter Q1 FY2027, filed October 22, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q1 FY2027, the quarter ended September 30, 2026, Procter & Gamble Company reported revenue of $23.3B, +4.0% on Q1 FY2026, and net income of $4.7B (−0.4%). Operating margin was 25.5%. Free cash flow, operating cash flow less capital expenditures, was $4.4B ($5.8B less $1.4B). Diluted earnings per share were $1.97.

The last 16 quarters

Q2 FY2023 to Q1 FY2027, through the filing of October 22, 2026.

Revenue and net incomeRevenueNet income
$0$10B$20B$30BQ2'23, Revenue: $20.8BQ2'23, Net income: $3.9BQ2'23Q3'23, Revenue: $20.1BQ3'23, Net income: $3.4BQ3'23Q4'23, Revenue: $20.6BQ4'23, Net income: $3.4BQ4'23Q1'24, Revenue: $21.9BQ1'24, Net income: $4.5BQ1'24Q2'24, Revenue: $21.4BQ2'24, Net income: $3.5BQ2'24Q3'24, Revenue: $20.2BQ3'24, Net income: $3.8BQ3'24Q4'24, Revenue: $20.5BQ4'24, Net income: $3.1BQ4'24Q1'25, Revenue: $21.7BQ1'25, Net income: $4.0BQ1'25Q2'25, Revenue: $21.9BQ2'25, Net income: $4.6BQ2'25Q3'25, Revenue: $19.8BQ3'25, Net income: $3.8BQ3'25Q4'25, Revenue: $20.9BQ4'25, Net income: $3.6BQ4'25Q1'26, Revenue: $22.4BQ1'26, Net income: $4.8BQ1'26Q2'26, Revenue: $22.2BQ2'26, Net income: $4.3BQ2'26Q3'26, Revenue: $21.2BQ3'26, Net income: $3.9BQ3'26Q4'26, Revenue: $21.2BQ4'26, Net income: $3.0BQ4'26Q1'27, Revenue: $23.3BQ1'27, Net income: $4.7BQ1'27$0$10B$20B$30BQ2'23, Revenue: $20.8BQ2'23, Net income: $3.9BQ3'23, Revenue: $20.1BQ3'23, Net income: $3.4BQ3'23Q4'23, Revenue: $20.6BQ4'23, Net income: $3.4BQ1'24, Revenue: $21.9BQ1'24, Net income: $4.5BQ1'24Q2'24, Revenue: $21.4BQ2'24, Net income: $3.5BQ3'24, Revenue: $20.2BQ3'24, Net income: $3.8BQ3'24Q4'24, Revenue: $20.5BQ4'24, Net income: $3.1BQ1'25, Revenue: $21.7BQ1'25, Net income: $4.0BQ1'25Q2'25, Revenue: $21.9BQ2'25, Net income: $4.6BQ3'25, Revenue: $19.8BQ3'25, Net income: $3.8BQ3'25Q4'25, Revenue: $20.9BQ4'25, Net income: $3.6BQ1'26, Revenue: $22.4BQ1'26, Net income: $4.8BQ1'26Q2'26, Revenue: $22.2BQ2'26, Net income: $4.3BQ3'26, Revenue: $21.2BQ3'26, Net income: $3.9BQ3'26Q4'26, Revenue: $21.2BQ4'26, Net income: $3.0BQ1'27, Revenue: $23.3BQ1'27, Net income: $4.7BQ1'27

Net income losses drawn in red.

Free cash flow
$0$2B$4B$6BQ2'23, Free cash flow: $2.9BQ2'23Q3'23, Free cash flow: $3.1BQ3'23Q4'23, Free cash flow: $4.6BQ4'23Q1'24, Free cash flow: $4.0BQ1'24Q2'24, Free cash flow: $4.3BQ2'24Q3'24, Free cash flow: $3.3BQ3'24Q4'24, Free cash flow: $5.0BQ4'24Q1'25, Free cash flow: $3.3BQ1'25Q2'25, Free cash flow: $3.9BQ2'25Q3'25, Free cash flow: $2.8BQ3'25Q4'25, Free cash flow: $4.0BQ4'25Q1'26, Free cash flow: $4.2BQ1'26Q2'26, Free cash flow: $3.8BQ2'26Q3'26, Free cash flow: $3.0BQ3'26Q4'26, Free cash flow: $4.1BQ4'26Q1'27, Free cash flow: $4.4BQ1'27$0$2B$4B$6BQ2'23, Free cash flow: $2.9BQ3'23, Free cash flow: $3.1BQ3'23Q4'23, Free cash flow: $4.6BQ1'24, Free cash flow: $4.0BQ1'24Q2'24, Free cash flow: $4.3BQ3'24, Free cash flow: $3.3BQ3'24Q4'24, Free cash flow: $5.0BQ1'25, Free cash flow: $3.3BQ1'25Q2'25, Free cash flow: $3.9BQ3'25, Free cash flow: $2.8BQ3'25Q4'25, Free cash flow: $4.0BQ1'26, Free cash flow: $4.2BQ1'26Q2'26, Free cash flow: $3.8BQ3'26, Free cash flow: $3.0BQ3'26Q4'26, Free cash flow: $4.1BQ1'27, Free cash flow: $4.4BQ1'27

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$10B$20B$30BQ2'23, Long-term debt: $20.6BQ2'23Q3'23, Long-term debt: $22.9BQ3'23Q4'23, Long-term debt: $24.4BQ4'23Q1'24, Long-term debt: $24.1BQ1'24Q2'24, Long-term debt: $23.1BQ2'24Q3'24, Long-term debt: $24.3BQ3'24Q4'24, Long-term debt: $25.3BQ4'24Q1'25, Long-term debt: $25.7BQ1'25Q2'25, Long-term debt: $25.3BQ2'25Q3'25, Long-term debt: $24.3BQ3'25Q4'25, Long-term debt: $25.0BQ4'25Q1'26, Long-term debt: $24.3BQ1'26Q2'26, Long-term debt: $25.6BQ2'26Q3'26, Long-term debt: $23.9BQ3'26Q4'26, Long-term debt: $22.8BQ4'26Q1'27, Long-term debt: $21.9BQ1'27$0$10B$20B$30BQ2'23, Long-term debt: $20.6BQ3'23, Long-term debt: $22.9BQ3'23Q4'23, Long-term debt: $24.4BQ1'24, Long-term debt: $24.1BQ1'24Q2'24, Long-term debt: $23.1BQ3'24, Long-term debt: $24.3BQ3'24Q4'24, Long-term debt: $25.3BQ1'25, Long-term debt: $25.7BQ1'25Q2'25, Long-term debt: $25.3BQ3'25, Long-term debt: $24.3BQ3'25Q4'25, Long-term debt: $25.0BQ1'26, Long-term debt: $24.3BQ1'26Q2'26, Long-term debt: $25.6BQ3'26, Long-term debt: $23.9BQ3'26Q4'26, Long-term debt: $22.8BQ1'27, Long-term debt: $21.9BQ1'27

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q1 FY2027 filed October 22, 2026.

Procter & Gamble Company income statement, quarterly
Millions of dollarsQ1 FY2027ended Sep 30, 2026filed Oct 22, 2026Q4 FY2026ended Jun 30, 2026filed Aug 4, 2026Q3 FY2026ended Mar 31, 2026filed Apr 24, 2026Q2 FY2026ended Dec 31, 2025filed Jan 23, 2026Q1 FY2026ended Sep 30, 2025filed Oct 24, 2025Q4 FY2025ended Jun 30, 2025filed Aug 4, 2025Q3 FY2025ended Mar 31, 2025filed Apr 24, 2025Q2 FY2025ended Dec 31, 2024filed Jan 22, 2025YoYQ1 FY2027vs Q1 FY2026
Revenue23,27621,20421,23522,20822,38620,88919,77621,882+4.0%
Cost of revenue11,67810,92010,72210,83410,88710,6319,69410,418+7.3%
Gross profit—————————
Research and development—————————
Selling, general and administrative5,6616,3345,9366,0085,6435,9045,5245,723+0.3%
Operating income5,9373,9504,5765,3665,8564,3554,5585,741+1.4%
Other income (expense)207112537160268274210224−22.8%
Pretax income—————————
Income tax1,2678521,0391,0901,2538958681,187+1.1%
Net income4,7313,0443,9324,3194,7503,6153,7694,630−0.4%
Diluted EPS ($)1.97—1.631.781.95—1.541.88+1.0%
Diluted shares (millions)2,407—2,4172,4242,437—2,4502,458—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q1 FY2027 filed October 22, 2026.

Procter & Gamble Company balance sheet, quarterly
Millions of dollarsQ1 FY2027ended Sep 30, 2026filed Oct 22, 2026Q4 FY2026ended Jun 30, 2026filed Aug 4, 2026Q3 FY2026ended Mar 31, 2026filed Apr 24, 2026Q2 FY2026ended Dec 31, 2025filed Jan 23, 2026Q1 FY2026ended Sep 30, 2025filed Oct 24, 2025Q4 FY2025ended Jun 30, 2025filed Aug 4, 2025Q3 FY2025ended Mar 31, 2025filed Apr 24, 2025Q2 FY2025ended Dec 31, 2024filed Jan 22, 2025YoYQ1 FY2027vs Q1 FY2026
Cash and equivalents—————————
Short-term investments—————————
Total current assets32,50826,20827,98726,58827,11825,39224,43525,642+19.9%
Total assets133,132126,521128,378127,286127,599125,231122,984122,639+4.3%
Total current liabilities44,99638,69438,23536,69937,99536,05834,24833,797+18.4%
Long-term debt21,89722,84223,85225,57724,31524,99524,25225,263−9.9%
Total liabilities77,79572,21073,64773,96974,04872,94670,43971,195+5.1%
Stockholders’ equity55,33754,31154,73153,31753,55152,28452,54551,443+3.3%
Shares outstanding (millions)2,3182,3242,3292,3242,3372,3422,3452,345—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q1 FY2027 filed October 22, 2026.

Procter & Gamble Company cash flow statement, quarterly
Millions of dollarsQ1 FY2027ended Sep 30, 2026filed Oct 22, 2026Q4 FY2026ended Jun 30, 2026filed Aug 4, 2026Q3 FY2026ended Mar 31, 2026filed Apr 24, 2026Q2 FY2026ended Dec 31, 2025filed Jan 23, 2026Q1 FY2026ended Sep 30, 2025filed Oct 24, 2025Q4 FY2025ended Jun 30, 2025filed Aug 4, 2025Q3 FY2025ended Mar 31, 2025filed Apr 24, 2025Q2 FY2025ended Dec 31, 2024filed Jan 22, 2025YoYQ1 FY2027vs Q1 FY2026
Operating cash flow5,7675,1314,0454,9725,4084,9853,7054,825+6.6%
Capital expenditures1,3661,0231,0191,1671,200996859925+13.8%
Free cash flow (CFO − capex)4,4014,1083,0263,8054,2083,9892,8463,900+4.6%
Depreciation and amortization810812785803761723690706+6.4%
Share repurchases1,2508756252,2781,2507001,3512,5100.0%
Dividends paid2,6032,6092,5302,5442,5492,5532,4332,441+2.1%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2026 filed August 4, 2026.

Income statement

Procter & Gamble Company income statement, annual
Millions of dollarsFY2026ended Jun 30, 2026filed Aug 4, 2026FY2025ended Jun 30, 2025filed Aug 4, 2025FY2024ended Jun 30, 2024filed Aug 5, 2024FY2023ended Jun 30, 2023filed Aug 4, 2023FY2022ended Jun 30, 2022filed Aug 5, 2022FY2021ended Jun 30, 2021filed Aug 6, 2021FY2020ended Jun 30, 2020filed Aug 6, 2020FY2019ended Jun 30, 2019filed Aug 6, 2019FY2018ended Jun 30, 2018filed Aug 7, 2018FY2017ended Jun 30, 2017filed Aug 7, 2017FY2016ended Jun 30, 2016filed Aug 9, 2016FY2015ended Jun 30, 2015filed Aug 7, 2015FY2014ended Jun 30, 2014filed Aug 8, 2014FY2013ended Jun 30, 2013filed Aug 8, 2013FY2012ended Jun 30, 2012filed Aug 8, 2012FY2011ended Jun 30, 2011filed Aug 10, 2011FY2010ended Jun 30, 2010filed Aug 13, 2010FY2009ended Jun 30, 2009filed Oct 29, 2009FY2008ended Jun 30, 2008filed Oct 29, 2009
Revenue87,03284,28484,03982,00680,18776,11870,95067,68466,83265,05865,29970,74974,40180,11628,40081,10477,56776,69479,257
Cost of revenue43,36241,16440,84842,76042,15737,10835,25034,76834,43232,638—————————
Gross profit———————————————————
Research and development2,1002,1002,0002,0002,0001,9001,8001,9001,9001,9001,9002,0001,9001,9002,0002,000———
Selling, general and administrative23,92222,66923,30521,11220,21721,02419,99419,08419,03718,65418,94920,61621,46126,00025,98425,75024,79322,63024,017
Operating income19,74820,45118,54518,13417,81317,98615,7065,48713,36313,76613,44111,04913,91013,81713,03515,49515,73215,37415,979
Other income (expense)1,07615466866857086438871222(215)32544020994118527182397373
Pretax income20,37720,16718,76118,35317,995——————————————
Income tax4,2334,1023,7873,6153,2023,2632,7312,1033,4653,0633,3422,7252,8513,2263,3783,2994,0173,7333,594
Net income16,04615,97414,87914,65314,74214,30613,0273,8979,75015,32610,5087,03611,64311,31210,75611,79712,73613,43612,075
Diluted EPS ($)6.626.516.025.905.815.504.961.433.675.593.692.444.013.863.663.934.114.263.64
Diluted shares (millions)2,4232,4542,4722,4842,5392,6012,6262,5402,6572,7402,8442,8842,9052,9312,9413,0023,0993,1543,317

Balance sheet

Procter & Gamble Company balance sheet, annual
Millions of dollarsFY2026ended Jun 30, 2026filed Aug 4, 2026FY2025ended Jun 30, 2025filed Aug 4, 2025FY2024ended Jun 30, 2024filed Aug 5, 2024FY2023ended Jun 30, 2023filed Aug 4, 2023FY2022ended Jun 30, 2022filed Aug 5, 2022FY2021ended Jun 30, 2021filed Aug 6, 2021FY2020ended Jun 30, 2020filed Aug 6, 2020FY2019ended Jun 30, 2019filed Aug 6, 2019FY2018ended Jun 30, 2018filed Aug 7, 2018FY2017ended Jun 30, 2017filed Aug 7, 2017FY2016ended Jun 30, 2016filed Aug 9, 2016FY2015ended Jun 30, 2015filed Aug 7, 2015FY2014ended Jun 30, 2014filed Aug 8, 2014FY2013ended Jun 30, 2013filed Aug 8, 2013FY2012ended Jun 30, 2012filed Aug 8, 2012FY2011ended Jun 30, 2011filed Aug 10, 2011FY2010ended Jun 30, 2010filed Aug 13, 2010FY2009ended Jun 30, 2009filed Oct 29, 2009FY2008ended Jun 30, 2008filed Oct 29, 2009
Cash and equivalents———————4,2392,5695,5698,0986,8368,5485,9304,4362,7682,8794,7813,313
Short-term investments———————————————————
Total current assets26,20825,39224,70922,64821,65323,09127,98722,47323,32026,49433,78229,64631,61723,99021,91021,97018,78221,905—
Total assets126,521125,231122,370120,829117,208119,307120,700115,095118,310120,406127,136129,495144,266139,263132,244138,354128,172134,833143,992
Total current liabilities38,69436,05833,62735,75633,08133,13232,97630,01128,23730,21030,77029,79033,72630,03724,90727,29324,28230,901—
Long-term debt22,84224,99525,26924,37822,84823,09923,53720,39520,86318,03818,94518,32719,81119,11121,08022,03321,36020,652—
Total liabilities72,21072,94671,81173,76470,35472,65373,82267,51665,42764,62869,15366,44574,29070,55468,20970,35366,73371,451—
Stockholders’ equity54,31152,28450,55947,06546,85446,65446,87847,57952,88355,77857,98363,05069,97668,70964,03568,00161,43963,38269,784
Shares outstanding (millions)2,3242,3422,3542,3572,3902,4272,4862,5022,4882,5502,6692,7132,7082,7392,7542,7482,8382,922—

Cash flow statement

Procter & Gamble Company cash flow statement, annual
Millions of dollarsFY2026ended Jun 30, 2026filed Aug 4, 2026FY2025ended Jun 30, 2025filed Aug 4, 2025FY2024ended Jun 30, 2024filed Aug 5, 2024FY2023ended Jun 30, 2023filed Aug 4, 2023FY2022ended Jun 30, 2022filed Aug 5, 2022FY2021ended Jun 30, 2021filed Aug 6, 2021FY2020ended Jun 30, 2020filed Aug 6, 2020FY2019ended Jun 30, 2019filed Aug 6, 2019FY2018ended Jun 30, 2018filed Aug 7, 2018FY2017ended Jun 30, 2017filed Aug 7, 2017FY2016ended Jun 30, 2016filed Aug 9, 2016FY2015ended Jun 30, 2015filed Aug 7, 2015FY2014ended Jun 30, 2014filed Aug 8, 2014FY2013ended Jun 30, 2013filed Aug 8, 2013FY2012ended Jun 30, 2012filed Aug 8, 2012FY2011ended Jun 30, 2011filed Aug 10, 2011FY2010ended Jun 30, 2010filed Aug 13, 2010FY2009ended Jun 30, 2009filed Oct 29, 2009FY2008ended Jun 30, 2008filed Oct 29, 2009
Operating cash flow19,55617,81719,84616,84816,72318,37117,40315,24214,86712,75315,43514,60813,95814,87313,28413,33016,13114,91915,008
Capital expenditures4,4093,7733,3223,0623,1562,7873,0733,3473,7173,3843,3143,7363,8484,0083,9643,3063,0673,2383,046
Free cash flow (CFO − capex)15,14714,04416,52413,78613,56715,58414,33011,89511,1509,36912,12110,87210,11010,8659,32010,02413,06411,68111,962
Depreciation and amortization3,1602,8472,8962,7142,8072,7353,0132,8242,8342,8203,0783,1343,1412,9823,2042,8383,1083,0823,166
Share repurchases5,0286,5005,0067,35310,00311,0097,4055,0037,0045,2044,0044,6046,0055,9864,0247,0396,0046,37010,047
Dividends paid10,2329,8729,3128,9998,7708,2637,7897,4987,3107,2367,4367,2876,9116,5196,1395,7675,4585,0444,655

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$15M
21 sales by 12 insiders; officers and directors $15M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$70M
34 sales by 15 insiders; officers and directors $70M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 23, 2026Jejurikar ShaileshChairman, President and CEO, Directoroption exercise35,000$78.52$3M90,391Oct 26, 2026
Oct 23, 2026Jejurikar ShaileshChairman, President and CEO, Directoropen-market sale35,000$163.09$6M55,391Oct 26, 2026
Oct 23, 2026Purushothaman BalajiChief Human Resources Officeropen-market sale4,181$160.71$672K11,296Oct 26, 2026
Oct 23, 2026Gama PaulCEO- Health Careopen-market sale4,331$161.27$698K46,793Oct 26, 2026
Oct 13, 2026Subramaniam RajeshDirectoraward1,438$0.00—7,768Oct 14, 2026
Oct 13, 2026Portman Robert JonesDirectoraward1,438$0.00—6,685Oct 14, 2026
Oct 13, 2026McEvoy AshleyDirectoraward1,438$0.00—7,666Oct 14, 2026
Oct 13, 2026McCarthy Christine MDirectoraward1,438$0.00—19,342Oct 14, 2026
Oct 13, 2026Kempczinski Christopher JDirectoraward1,438$0.00—13,372Oct 14, 2026
Oct 13, 2026Jimenez JosephDirectoraward1,438$0.00—38,968Oct 14, 2026
Oct 13, 2026Chang AmyDirectoraward1,438$0.00—18,897Oct 14, 2026
Oct 13, 2026Bonini SheilaDirectoraward1,438$0.00—5,983Oct 14, 2026
Oct 13, 2026Biggs M. BrettDirectoraward1,438$0.00—6,900Oct 14, 2026
Oct 13, 2026Arnold CraigDirectoraward1,438$0.00—4,474Oct 14, 2026
Oct 13, 2026Allen Bertrand MarcDirectoraward1,438$0.00—12,698Oct 14, 2026
Oct 5, 2026Schulten AndreChief Financial Officeropen-market sale3,914$145.34$569K65,618Oct 6, 2026
Oct 5, 2026Gama PaulCEO- Health Careopen-market sale2,225$145.34$323K51,124Oct 6, 2026
Oct 5, 2026Whaley Susan StreetChief Legal Officer & Secyopen-market sale2,369$145.34$344K30,730Oct 6, 2026
Oct 1, 2026Whaley Susan StreetChief Legal Officer & Secyaward6,110$0.00—33,099Oct 5, 2026
Oct 1, 2026Schulten AndreChief Financial Officeraward6,557$0.00—69,532Oct 5, 2026
Oct 1, 2026Gama PaulCEO- Health Careaward12,517$0.00—53,349Oct 5, 2026
Oct 1, 2026Jejurikar ShaileshChairman, President and CEO, Directoraward16,065$0.00—55,391Oct 5, 2026
Oct 1, 2026Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officeraward5,732$0.00—55,243Oct 5, 2026
Oct 1, 2026Santos de Azevedo Juliana MonteiroCEO - Groomingaward3,130$0.00—26,731Oct 5, 2026
Sep 8, 2026Portman Robert JonesDirectoraward52$0.00—5,247Sep 10, 2026

Full insider history for Procter & Gamble Company, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held PG in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded PG by quarter.

FundManagerQuarterValueSharesWeightMove
FundsmithTerry SmithQ2 2026$598M4M4.38%trimmed −2.9%

Sources

Fiscal year ends in month 6; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
PROCTER & GAMBLE CO, CIK 80424 on EDGAR
Extract generated
October 23, 2026
Withheld
7 line-years whose four quarters do not sum to the filed year: revenue FY2010, operating income FY2012, revenue FY2012, operating income FY2013, revenue FY2013, operating income FY2014, revenue FY2014
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: not filed
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated October 23, 2026.

JSON file
/data/financials/PG.json